Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda Compadre

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Gynecologic Oncology Reports|March 30, 2026
Developing patient-centered educational material to improve colposcopy adherenceRida Qureshi, Naomi Peck, Amanda Compadre, et al.
Journal of Visualized Experiments : Jove|March 13, 2023
Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence AssaysLillian van Biljon, Bisiayo Fashemi, Jeimmy Rodriguez, et al.
Biorxiv : the Preprint Server for Biology|December 19, 2025
Targeting ALC1 can safely expand the therapeutic utility of PARP inhibitors across high-grade serous ovarian cancersLindsey N Aubuchon, Deanna H Wong, Natasha M Ramakrishnan, et al.
Gynecologic Oncology|July 6, 2024
A toolkit for a modern gynecologic oncology tissue bankOlivia Graham, Jeimmy Rodriguez, Rachel Abbott, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
Replication stress marker phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancerAngela Schab, Amanda Compadre, Rikki Drexler, et al.
The Journal of Clinical Investigation|May 20, 2025
Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancerAngela Schab, Amanda Compadre, Rebecca Drexler, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Gynecologic Oncology Reports|March 30, 2026
Developing patient-centered educational material to improve colposcopy adherenceRida Qureshi, Naomi Peck, Amanda Compadre, et al.
Journal of Visualized Experiments : Jove|March 13, 2023
Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence AssaysLillian van Biljon, Bisiayo Fashemi, Jeimmy Rodriguez, et al.
Biorxiv : the Preprint Server for Biology|December 19, 2025
Targeting ALC1 can safely expand the therapeutic utility of PARP inhibitors across high-grade serous ovarian cancersLindsey N Aubuchon, Deanna H Wong, Natasha M Ramakrishnan, et al.
Gynecologic Oncology|July 6, 2024
A toolkit for a modern gynecologic oncology tissue bankOlivia Graham, Jeimmy Rodriguez, Rachel Abbott, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
Replication stress marker phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancerAngela Schab, Amanda Compadre, Rikki Drexler, et al.
The Journal of Clinical Investigation|May 20, 2025
Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancerAngela Schab, Amanda Compadre, Rebecca Drexler, et al.
Pageof 1